Cite
Wu R, Geng L, Zhao Z, et al. Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer. Front Oncol. 2020;10:562147doi: 10.3389/fonc.2020.562147.
Wu, R., Geng, L., Zhao, Z., Liao, D., He, B., Hu, H., Lin, Y., Li, M., Xiang, M., Zhang, Y., Feng, G., Tan, B., & Du, X. (2020). Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer. Frontiers in oncology, 10562147. https://doi.org/10.3389/fonc.2020.562147
Wu, Rong, et al. "Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer." Frontiers in oncology vol. 10 (2020): 562147. doi: https://doi.org/10.3389/fonc.2020.562147
Wu R, Geng L, Zhao Z, Liao D, He B, Hu H, Lin Y, Li M, Xiang M, Zhang Y, Feng G, Tan B, Du X. Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer. Front Oncol. 2020 Oct 02;10:562147. doi: 10.3389/fonc.2020.562147. eCollection 2020. PMID: 33123474; PMCID: PMC7566907.
Copy
Download .nbib